Published on in Vol 6, No 7 (2022): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41121, first published .
Correction: Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study

Correction: Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study

Correction: Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study

Corrigenda and Addenda

Corresponding Author:

Lauren Broffman, DPhil

Ro

116 West 23rd Street

New York, NY, 10011

United States

Phone: 1 888 798 8686

Email: lauren.broffman@ro.co



In “Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study” (JMIR Form Res 2022;6(1):e32126), the authors noted the following corrections:

1. In Table 1, the values for each side effect - headache, dizziness, flushing, congestion, dyspepsia, back pain, and blurry vision - were mislabeled. Values categorized as ‘asynchronous’ should have been labeled ‘synchronous’ and vice versa. No values were incorrectly referenced in the text of the article and this error does not impact the overall interpretation of results.

2. In the original paper, the following sentence was present in the Discussion section:

The recent widespread adoption of telehealth as an acceptable treatment modality and the exploration for potential expansion of traditional methods outside the scope of synchronous care have prompted deeper exploration of the downstream effects of these approaches to care distribution.

This has been changed to:

The recent widespread adoption of telehealth as an acceptable treatment modality and the potential expansion of asynchronous care have prompted deeper exploration of the downstream effects.

3. The phone number of the corresponding author, Lauren Broffman, has been updated to 1 888 798 8686.

Table 1. Rates of reported side effects by modality.
Side effectsSynchronous (n=2150)Asynchronous (n=7850)
Any side effect, n (%)24 (1.12)113 (1.44)
Headache, n (%)10 (0.47)56 (0.71)
Dizziness, n (%)0 (0)3 (0.04)
Flushing, n (%)2 (0.09)31 (0.39)
Congestion, n (%)12 (0.56)17 (0.22)
Dyspepsia, n (%)7 (0.33)10 (0.13)
Back pain, n (%)0 (0)6 (0.08)
Blurry vision, n (%)2 (0.09)8 (0.10)
Other, n (%)2 (0.09)7 (0.09)

The correction will appear in the online version of the paper on the JMIR Publications website on July 27, 2022, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.

This is a non–peer-reviewed article. submitted 15.07.22; accepted 15.07.22; published 27.07.22.

Copyright

©Lauren Broffman, Melynda Barnes, Kevin Stern, Amy Westergren. Originally published in JMIR Formative Research (https://formative.jmir.org), 27.07.2022.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.